Use my Search Websuite to scan PubMed, PMCentral, Journal Hosts and Journal Archives, FullText. Kick-your-searchterm to multiple Engines kick-your-query now !>

A dictionary by aggregated review articles of nephrology, medicine and the life sciences Your one-stop-run pathway from word to the immediate pdf of peer-reviewed on-topic knowledge.

10.3760/cma.j.cn501113-20200416-00190 http://scihub22266oqcxt.onion/10.3760/cma.j.cn501113-20200416-00190 32660185!ä!32660185 Warning: Undefined variable $yww in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 538 Warning: Undefined variable $yww in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 538       Zhonghua+Gan+Zang+Bing+Za+Zhi 2020 ; 28 (6): 523-527 Nephropedia Template TP {{tp|p=32660185|t=2020. Research progress on the clinical features and mechanisms of COVID-19 combined with liver injury |pdf=|usr=}}{{32660185}} gab.com Text Research progress on the clinical features and mechanisms of COVID-19 combined with liver injury JO: Zhonghua Gan Zang Bing Za Zhi http://www.kidney.de/pget.php?&tw=1&pmid=32660185 #FOAvip The highly contagious novel coronavirus pneumonia (COVID-19) that broke out in December 2019 has brought huge threats and losses to human society, so it has been the concern of every countries government. Presently, there are no specific drugs for COVID-19; however, a variety of potentially effective antiviral drugs, vaccines, cell therapies, traditional Chinese medicine and other methods are in clinical trials. Liver injury is a common complication of patients receiving COVID-19 treatment and its possible high incidence may affect the outcome of the disease. The pathogenesis of COVID-19 combined with liver injury in existing studies is still unclear, and relevant guidelines and expert consensuses are insufficient for clinical diagnosis and treatment. Therefore, the relevant progress and issues are now reviewed here. Twit Text FOAVip Research progress on the clinical features and mechanisms of COVID-19 combined with liver injury ????Zhonghua Gan Zang Bing Za Zhi http://www.kidney.de/pget.php?&tw=1&pmid=32660185 #FOAvip Twit Text # Free Paper on # # # # # LINK http://www.kidney.de/pget.php?&tw=1&pmid=32660185 #FOAvip English Wikipedia <ref>{{Cite pmid|32660185}}</ref> Research progress on the clinical features and mechanisms of COVID-19 combined with liver injury #MMPMID32660185 Xie YB; Wang SY; Zhang C; Wang FS Zhonghua Gan Zang Bing Za Zhi 2020[Jun]; 28 (6): 523-527 PMID32660185show ga The highly contagious novel coronavirus pneumonia (COVID-19) that broke out in December 2019 has brought huge threats and losses to human society, so it has been the concern of every countries government. Presently, there are no specific drugs for COVID-19; however, a variety of potentially effective antiviral drugs, vaccines, cell therapies, traditional Chinese medicine and other methods are in clinical trials. Liver injury is a common complication of patients receiving COVID-19 treatment and its possible high incidence may affect the outcome of the disease. The pathogenesis of COVID-19 combined with liver injury in existing studies is still unclear, and relevant guidelines and expert consensuses are insufficient for clinical diagnosis and treatment. Therefore, the relevant progress and issues are now reviewed here. |*Betacoronavirus[MESH] |*Coronavirus Infections/complications/drug therapy[MESH] |*Pandemics[MESH] |*Pneumonia, Viral/complications[MESH] |COVID-19[MESH] |COVID-19 Drug Treatment[MESH] |Humans[MESH] |Liver[MESH] |Liver Diseases/*etiology[MESH] Research progress on the clinical features and mechanisms of COVID-19(epmc).pdf DeepDyve Pubget Overpricing